Covered recipient · General Payments record
JOHN TAYLOR HENSON
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2018–2024
$3,731.06
- Reported across 211 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $446.37 | 27 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $133.36 | 9 |
| Lilly USA, LLC | $113.19 | 7 |
| DEXCOM, INC. | $39.70 | 2 |
| Acerta Pharma LLC | $38.07 | 2 |
| PFIZER INC. | $36.19 | 2 |
| Exact Sciences Corporation | $33.28 | 2 |
| ABBVIE INC. | $29.29 | 2 |
| Axsome Therapeutics, Inc. | $23.29 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (27)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $14.42 | 03/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103906890 | CMS |
| ABBVIE INC. | $14.87 | 07/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103906892 | CMS |
| AstraZeneca Pharmaceuticals LP | $18.60 | 01/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104650823 | CMS |
| AstraZeneca Pharmaceuticals LP | $19.47 | 06/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105544233 | CMS |
| Axsome Therapeutics, Inc. | $23.29 | 02/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148286185 | CMS |
| Dexcom, Inc. | $19.04 | 05/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153305137 | CMS |
| Dexcom, Inc. | $20.66 | 11/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153305139 | CMS |
| Exact Sciences Corporation | $19.05 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114699656 | CMS |
| Exact Sciences Corporation | $14.23 | 07/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114699663 | CMS |
| Lilly USA, LLC | $15.91 | 01/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135031282 | CMS |
| Lilly USA, LLC | $18.60 | 02/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134987756 | CMS |
| Lilly USA, LLC | $15.43 | 03/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135013623 | CMS |
| Lilly USA, LLC | $15.83 | 04/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135032500 | CMS |
| Lilly USA, LLC | $17.99 | 06/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135011861 | CMS |
| Lilly USA, LLC | $14.12 | 07/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135037757 | CMS |
| Lilly USA, LLC | $15.31 | 11/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135031280 | CMS |
| Novo Nordisk Inc | $15.61 | 01/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096990488 | CMS |
| Novo Nordisk Inc | $15.71 | 03/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097615546 | CMS |
| Novo Nordisk Inc | $12.84 | 07/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096665368 | CMS |
| Novo Nordisk Inc | $18.04 | 08/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097213753 | CMS |
| Novo Nordisk Inc | $4.91 | 08/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096575143 | CMS |
| Novo Nordisk Inc | $14.79 | 09/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096757257 | CMS |
| Novo Nordisk Inc | $16.47 | 10/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097305450 | CMS |
| Novo Nordisk Inc | $20.98 | 12/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097374115 | CMS |
| Novo Nordisk Inc | $14.01 | 12/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097814530 | CMS |
| PFIZER INC. | $18.30 | 02/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131721998 | CMS |
| PFIZER INC. | $17.89 | 02/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132032054 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.